Head & Neck/Thyroid Cancers
Latest News
Burden of thyroid cancer: Substantial and increasing
Of 19 countries, 13 showed an average annual percentage increase in incidence rates.
From the Journals
New 3D printable stent holds promise for tracheal tumors
From the Journals
Radioactive iodine shows no benefit in low-risk thyroid cancer
The study’s take-home message for clinicians should be to “stop systematic radioiodine ablation administration in low-risk thyroid cancer patients...
Diminutio
Filling opioid prescriptions akin to a Sisyphean task
“Instead of preserving access to desperately needed pain medicine for those suffering with serious illness, states and insurers have aggressively...
Conference Coverage
Can liquid biopsy predict oropharyngeal cancer recurrence?
Latest News
Radiofrequency ablation an option for thyroid microcarcinoma
RFA might be a good option for high risk surgical patients and patients who forgo active surveillance.
Latest News
Radioactive iodine therapy linked to later malignancy
A SEER study confirms known risks, but also finds elevated rates of breast cancer.
Latest News
Nedaplatin chemo proves to be a less toxic option for nasopharyngeal carcinoma
Chemotherapy-induced toxic effects, such as renal dysfunction, have always been a major concern in nasopharyngeal carcinoma.
From the Journals
Brain tumors exact higher mortality toll in men than women
“We cannot discount the role of sex differences in diagnosis, treatment, or behavioral risk factors that may underlie the better survival for...
Diminutio
“I didn’t want to meet you.” Dispelling myths about palliative care
This is the first installment of “Diminutio,” a column by Sarah D’Ambruoso, NP, a palliative care nurse in oncology. Today, she shares stories...
Latest News
Confirmed: Pembro plus chemo as first-line standard of care for esophageal cancer
An interim analysis of KEYNOTE-590 found that the combination of pembrolizumab and chemotherapy as first-line treatment, proved superior to...